| Literature DB >> 22407339 |
Eivind Andersen1, Arne T Høstmark, Sigmund A Anderssen.
Abstract
Physical activity (PA) is thought to prevent the metabolic syndrome (MetS), which is prevalent among south Asian immigrants in Western countries. The purpose of this study was to explore whether increasing PA improves the MetS and associated components in a group of Pakistani immigrant men living in Norway. One- hundred and fifty physically inactive Pakistani immigrant men were randomized to either a control group (CG) or an intervention group (IG). The 5 months intervention focused on increasing PA level, which was assessed using accelerometer recordings. Total PA level (counts min(-1)) increased significantly more in the IG than in the CG. The mean difference between the two groups was 49 counts min(-1), which translates into a 15% (95% CI = 8.7% to 21.2%; P = 0.01) greater increase in total PA level in the IG than in the CG. Serum insulin concentration and waist circumference decreased more in the IG compared with the CG. Other MetS related factors and the prevalence of the MetS did not differ between the groups after the intervention. A five- month intervention program can increase PA level and cardiorespiratory fitness, and reduce insulin concentration and waist circumference. However this intervention program may not lower the prevalence of the complete MetS in Pakistani immigrant men.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22407339 PMCID: PMC3439616 DOI: 10.1007/s10903-012-9586-6
Source DB: PubMed Journal: J Immigr Minor Health ISSN: 1557-1912
Fig. 1The flow of participants through the trial
Overview of the intervention components, attendance rates, behaviour change strategies and targeted social cognitive constructs
| Intervention component | Dose | Description | Behaviour change strategy | Targeted construct |
|---|---|---|---|---|
| Structured group exercise | 60 min twice a week | Participants could choose to attend one out of five different exercise facilities in Oslo. The different exercise groups were led by an exercise physiologist. The exercise training programme was designed as a low threshold activity. The sessions had the following structure: a 15 min warm-up with easy and fun games, 40 min of floorball and/or football plus some strength exercises and a 5 min cool down. Seven participants did not attend any of the sessions (one trained by himself and six were not motivated) and two were injured at the first exercise session. The mean attendance was 60% (range: 11–100%). | Provide opportunities for PA Increase social support for PA Promote mastery learning through skill training Improve knowledge and skill to perform PA Promote positive outcomes of PA Provide credible role models for PA | Environment Expectancies Self-efficacy |
| Group lectures | 2 × 2 h | The lectures were conducted at the Norwegian School of Sports Sciences. The project leader led the classes. Major topics were: What is PA? PA and health link; short- and long term effects The harms of physical inactivity PA recommendations and how to achieve these Activity examples Setting small goals Identifying and reducing perceived barriers Making a PA plan Seeking social support Self reward Both attendees (95%) and non-attendees received written summaries of the lecturers. | Improve knowledge of PA options, including non-vigorous PA Improve knowledge on how to incorporate PA into the daily routine Enhance PA expectancies Improve goal setting for PA Improve problem solving of PA barriers Improve social support for PA | Social support Expectancies Self-efficacy |
| Individual counselling sessions | 1 h | The counselling was based on the concept that all advice must match the participants’ experience of PA and degree of motivation. Together with the participant, the primary goal was to find activities that could be implemented in a usual week, with the sum of these activities enabling them to reach the PA recommendations. After discussing activity options, the participants set the goals they wanted to achieve over the five-month period. Finally, we discussed barriers by asking “What do you think can stop you from carrying out this activity plan?”, and the possible barriers, and solutions to them were discussed and written down. All participants completed this part of the intervention. | Identify opportunities for PA Improve knowledge and skill to perform PA Enhance goal setting for PA Promote mastery for PA Identify and problem solve barriers to PA | Social support Self-efficacy Expectancies |
| Phone call | 5–15 min | T Three to five weeks before the first follow-up test, intervention participants in the intervention group were telephoned to discuss the activity plan, to make changes if necessary, and to encourage further efforts. All participants were reached within three attempts. | Provide feedback on PA behaviour Reinforce problem solving for PA Provide encouragement and help | Social support Self-efficacy |
Baseline descriptive characteristics of the intervention and control group
| Characteristic | Intervention group ( | Control group ( | Mean difference (95% CI) |
|---|---|---|---|
| Age (years) | 35.7 (6.1) | 39.7 (9.2) | −3.9 (−6.6 to −1.2)* |
| MetS, | 46 (51) | 29 (47) | |
| No. of MetS components | 2.6 (1.1) | 2.5 (1.2) | 0.06 (−0.3 to 0.4) |
| Waist circumference (cm) | 98 (9) | 99 (11) | −1.1 (−4.6 to 2.3) |
| Triglycerides (mmol l−1) | 1.9 (1.8) | 2.0 (1.6) | −0.05 (−0.6 to 0.5) |
| HDLc (mmol l−1) | 1.0 (0.2) | 1.0 (0.2) | 0.0 (−0.08 to 0.09) |
| LDLc (mmol l−1) | 3.5 (0.6) | 3.4 (0.9) | 0.08 (−0.1 to 0.3) |
| Blood glucose (mmol l−1) | 5.3 (0.7) | 5.4 (1.1) | −0.1 (−0.5 to 0.1) |
| Systolic BP (mmHg) | 119 (11) | 119 (10) | −0.6 (−4.3 to 2.9) |
| Diastolic BP (mmHg) | 85 (9.0) | 85 (10) | 0.2 (−2.9 to 3.4) |
Data are presented as mean (SD) if not specified otherwise. SD standard deviation, CI confidence interval, MetS metabolic syndrome, HDLc high density lipoprotein cholesterol, LDLc low density lipoprotein cholesterol, BP blood pressure
a[10]
Changes in the number of participants with the metabolic syndrome
| Intervention group | Control group | Total | ||
|---|---|---|---|---|
| Resolution of the MetS | Number | 12 | 7 | 19 |
| Per cent | 16.9% | 13.7% | 15.6% | |
| Development of the MetS | Number | 8 | 9 | 17 |
| Per cent | 11.3% | 17.6% | 13.9% | |
| No change | Number | 51 | 35 | 86 |
| Per cent | 71.8% | 68.6% | 70.5% | |
| Total | Number | 71 | 51 | 122 |
| Per cent | 100.0% | 100.0% | 100.0% |
Forty-six (51%) of the participants in the intervention group and 29 (47%) of the participants in the control group had the metabolic syndrome (MetS) at baseline. After the 5 months, 31 (34%) of the participants in the intervention group and 26 (43%) of the participants in the control group had the MetS
Fig. 2Incidence (%) of the resolution (a) and the development (b) of components of the metabolic syndrome during the intervention period for the intervention group (black bars) and the control group (grey bars). HDLc high density lipoprotein cholesterol. BP blood pressure
Response differences in the control and intervention groups
| Characteristic | Intervention group | Control group |
|
| Effect size | Adjusted mean df ± 95% CI |
|---|---|---|---|---|---|---|
| No. of MetS components | −0.2 (0.1) | −0.03 (0.1) | 0.4 | 0.5 | −0.08 | −0.1 (−0.6 to 0.3) |
| Waist circumference (cm) | −1.9 (0.4) | 1.7 (0.4) | 25.2 | <0.01 | −1.06 | −3.4 (−4.7 to −2.0) |
| Triglycerides (mmol l−1) | 0.04 (0.1) | −0.02 (0.1) | 0.4 | 0.5 | 0.09 | 0.1 (−0.2 to 0.4) |
| HDLc (mmol l−1) | 0.00 (0.01) | −0.01 (0.01 | 0.1 | 0.7 | 0.08 | 0.008 (−0.03 to 0.05) |
| LDLc (mmol l−1) | −0.05(0.06) | 0.02 (0.09) | 1.1 | 0.2 | −0.12 | −0.07 (−0.3 to 0.1) |
| Glucose (mmol l−1) | −0.14 (0.05) | −0.06 (0.1) | 0.7 | 0.3 | −0.09 | −0.1 (−0.4 to 0.1) |
| Systolic BP (mmHg) | −1.7 (0.9) | 0.05 (1.3) | 1.0 | 0.3 | −0.17 | −1.6 (−5 to 1.6) |
| Diastolic BP (mmHg) | −3.8 (0.8) | −0.9 (1.0) | 3.1 | 0.08 | −0.34 | −2.5 (−5.3 to 0.3) |
* adjusted for age. SEM standard error of the mean, CI confidence intervals, MetS metabolic syndrome, HDLc high density lipoprotein cholesterol, LDLc low density lipoprotein cholesterol, BP blood pressure